CCM
EXAS

Coldstream Capital Management’s Exact Sciences EXAS Stock Holding History

Coldstream Capital Management’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,149
Closed -$218K – 1223
2025
Q4 		$218K Buy
+2,149
New +$173K ﹤0.01% 1051
2025
Q2 		– Sell
-1,943
Closed -$84.1K – 1826
2025
Q1 		$84.1K Buy
+1,943
New +$98.4K ﹤0.01% 1441

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Coldstream Capital Management's EXAS Position: Q1 2026 in Review

Coldstream Capital Management sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 2,149 shares — an estimated $218K sold.

Coldstream Capital Management first reported a position in EXAS in Q1 2025 and held it in 2 quarters. The position peaked at $218K in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Coldstream Capital Management reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Coldstream Capital Management sold 2,149 Exact Sciences shares in Q1 2026, an estimated $218K.
  • Coldstream Capital Management first reported a position in Exact Sciences in Q1 2025 and held it in 2 quarters.
  • Coldstream Capital Management's Exact Sciences position peaked at $218K in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Coldstream Capital Management's 13F filing for Q1 2026, filed 8 May 2026.